ATE190841T1 - Arzneimittel enthaltend argatroban analoga - Google Patents
Arzneimittel enthaltend argatroban analogaInfo
- Publication number
- ATE190841T1 ATE190841T1 AT94101051T AT94101051T ATE190841T1 AT E190841 T1 ATE190841 T1 AT E190841T1 AT 94101051 T AT94101051 T AT 94101051T AT 94101051 T AT94101051 T AT 94101051T AT E190841 T1 ATE190841 T1 AT E190841T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- polycyclic compound
- compound residue
- benzene ring
- condensed polycyclic
- Prior art date
Links
- KXNPVXPOPUZYGB-IOVMHBDKSA-N (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid Chemical class OC(=O)[C@H]1C[C@H](C)CCN1C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2 KXNPVXPOPUZYGB-IOVMHBDKSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- -1 polycyclic compound Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000004019 antithrombin Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000002960 lipid emulsion Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5010060A JPH06219948A (ja) | 1993-01-25 | 1993-01-25 | 抗トロンビン剤及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE190841T1 true ATE190841T1 (de) | 2000-04-15 |
Family
ID=11739847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94101051T ATE190841T1 (de) | 1993-01-25 | 1994-01-25 | Arzneimittel enthaltend argatroban analoga |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0608828B1 (de) |
| JP (1) | JPH06219948A (de) |
| AT (1) | ATE190841T1 (de) |
| CA (1) | CA2114153A1 (de) |
| DE (1) | DE69423528T2 (de) |
| ES (1) | ES2145067T3 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9426038D0 (en) | 1994-12-22 | 1995-02-22 | Iaf Biochem Int | Low molecular weight bicyclic thrombin inhibitors |
| US6057314A (en) * | 1995-12-21 | 2000-05-02 | Biochem Pharma Inc. | Low molecular weight bicyclic thrombin inhibitors |
| US5840733A (en) | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
| FR2795960B1 (fr) * | 1999-07-05 | 2001-10-19 | Sanofi Elf | Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions |
| AUPR510001A0 (en) * | 2001-05-18 | 2001-06-14 | Jupitar Pty Ltd | Formulation and method |
| JP2007008857A (ja) * | 2005-06-30 | 2007-01-18 | Nisshin Pharma Inc | 大豆油不けん化物含有組成物 |
| BRPI0616127B8 (pt) * | 2005-09-01 | 2021-05-25 | Baxter Healthcare Sa | solução farmacêutica aquosa, estéril, estável, injetável, e seu método de preparação |
| US7589106B2 (en) | 2006-09-27 | 2009-09-15 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
| US7687516B2 (en) | 2006-09-27 | 2010-03-30 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
| US7915290B2 (en) | 2008-02-29 | 2011-03-29 | Baxter International Inc. | Argatroban formulations and methods for making and using same |
| US20120271010A1 (en) * | 2009-12-24 | 2012-10-25 | Toray Industries, Inc. | Hydrophilic polymer compound having anticoagulation effect |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| CN107773533A (zh) * | 2016-08-26 | 2018-03-09 | 四川科瑞德制药股份有限公司 | 一种新型凝血酶抑制剂及其制备方法 |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE48623B1 (en) * | 1978-08-31 | 1985-03-20 | Mitsubishi Chem Ind | Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances |
| JPS61112018A (ja) * | 1984-11-06 | 1986-05-30 | Mitsubishi Chem Ind Ltd | 線溶増強剤 |
| JPS6431727A (en) * | 1987-07-28 | 1989-02-02 | Mitsubishi Chem Ind | Dissolution of argininamide and drug composition containing argininamides |
| JPH02129123A (ja) * | 1988-11-07 | 1990-05-17 | Mitsubishi Kasei Corp | 抗血液凝固剤 |
-
1993
- 1993-01-25 JP JP5010060A patent/JPH06219948A/ja active Pending
-
1994
- 1994-01-25 EP EP94101051A patent/EP0608828B1/de not_active Expired - Lifetime
- 1994-01-25 AT AT94101051T patent/ATE190841T1/de not_active IP Right Cessation
- 1994-01-25 CA CA002114153A patent/CA2114153A1/en not_active Abandoned
- 1994-01-25 DE DE69423528T patent/DE69423528T2/de not_active Expired - Fee Related
- 1994-01-25 ES ES94101051T patent/ES2145067T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2114153A1 (en) | 1994-07-26 |
| JPH06219948A (ja) | 1994-08-09 |
| ES2145067T3 (es) | 2000-07-01 |
| EP0608828B1 (de) | 2000-03-22 |
| DE69423528T2 (de) | 2000-09-14 |
| EP0608828A1 (de) | 1994-08-03 |
| DE69423528D1 (de) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE190841T1 (de) | Arzneimittel enthaltend argatroban analoga | |
| ES2190428T3 (es) | Antagonistas biciclicos de fibrinogeno. | |
| KR890011601A (ko) | (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약 | |
| NZ235251A (en) | Isoxazole derivatives, intermediates, preparation and herbicidal compositions thereof | |
| ATE21699T1 (de) | Verfahren zur herstellung von 2-penemverbindungen. | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| ATE190842T1 (de) | Arzneizusammensetzungen enthaltend argatrobananaloge | |
| KR910002800A (ko) | 4-아실록시퀴놀린 유도체와 이를 함유하는 살충 또는 살비조성물 | |
| HUT54350A (en) | Insecticidal and nematocidal plant protective compositions, process for producing veterinary compositions suitable for killing helminths and protozoa, as well as process for producing 1-arylimidazoles used as active ingredient | |
| KR970707122A (ko) | 퀴놀린 유도체(quinoline derivative) | |
| KR910006309A (ko) | 인지질 및 인지질 유도체를 유효 성분으로 하는 항비루스성 약제 | |
| KR920701120A (ko) | 치환된 비시클로헵탄디온 유도체 | |
| PT90986A (pt) | Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem | |
| PT91607A (pt) | Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them | |
| EP0712398A1 (de) | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen | |
| ES2059348T3 (es) | Composicion farmaceutica para el tratamiento de cataratas. | |
| KR830003170A (ko) | 해독제로서의 2-치환된-4-알킬 또는 트리할로알킬-5-옥사졸 카복실산 및 그의 유도체 | |
| DE3866292D1 (de) | Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| KR890701584A (ko) | 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물 | |
| KR890012973A (ko) | 이미다졸 유도체 | |
| KR930702339A (ko) | 에폭시숙시남산 유도체 | |
| PT88462A (pt) | Process for the preparation of macrolide compounds and of compositions containing them | |
| HUT48253A (en) | Herbicide compositions containing new macrolid compounds and process for producing new macrolid compounds and pharmaceutical compositions containing them as active components | |
| KR880013896A (ko) | 벤조푸로[3,2-c]퀴놀린 화합물 | |
| IL65213A0 (en) | Morpholine derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |